NasdaqGM - Delayed Quote USD

TELA Bio, Inc. (TELA)

4.7500 -0.4000 (-7.77%)
At close: April 19 at 4:00 PM EDT
4.7500 0.00 (0.00%)
After hours: April 19 at 7:37 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
58,453.0000
58,453.0000
41,418.0000
29,463.0000
18,213.0000
Cost of Revenue
18,341.0000
18,341.0000
14,374.0000
10,650.0000
6,979.0000
Gross Profit
40,112.0000
40,112.0000
27,044.0000
18,813.0000
11,234.0000
Operating Expense
84,187.0000
84,187.0000
66,051.0000
48,264.0000
36,509.0000
Operating Income
-44,075.0000
-44,075.0000
-39,007.0000
-29,451.0000
-25,275.0000
Net Non Operating Interest Income Expense
-5,223.0000
-5,223.0000
-4,051.0000
-3,597.0000
-3,564.0000
Other Income Expense
2,634.0000
2,634.0000
-1,238.0000
-228.0000
45.0000
Pretax Income
-46,664.0000
-46,664.0000
-44,296.0000
-33,276.0000
-28,794.0000
Net Income Common Stockholders
-46,664.0000
-46,664.0000
-44,296.0000
-33,276.0000
-28,794.0000
Diluted NI Available to Com Stockholders
-46,664.0000
-46,664.0000
-44,296.0000
-33,276.0000
-28,794.0000
Basic EPS
-2.04
--
-2.72
-2.30
-2.23
Diluted EPS
-2.04
--
-2.72
-2.30
-2.23
Basic Average Shares
22,868.6630
--
16,267.6780
14,473.2130
12,934.4210
Diluted Average Shares
22,868.6630
--
16,267.6780
14,473.2130
12,934.4210
Total Operating Income as Reported
-44,075.0000
-44,075.0000
-39,007.0000
-29,451.0000
-25,275.0000
Total Expenses
102,528.0000
102,528.0000
80,425.0000
58,914.0000
43,488.0000
Net Income from Continuing & Discontinued Operation
-46,664.0000
-46,664.0000
-44,296.0000
-33,276.0000
-28,794.0000
Normalized Income
-46,664.0000
-46,664.0000
-43,068.0000
-33,276.0000
-28,794.0000
Interest Expense
5,223.0000
5,223.0000
4,051.0000
3,597.0000
3,564.0000
Net Interest Income
-5,223.0000
-5,223.0000
-4,051.0000
-3,597.0000
-3,564.0000
EBIT
-41,441.0000
-41,441.0000
-40,245.0000
-29,679.0000
-25,230.0000
EBITDA
-40,633.0000
-40,633.0000
-39,058.0000
-29,144.0000
-24,705.0000
Reconciled Cost of Revenue
18,341.0000
18,341.0000
14,374.0000
10,650.0000
6,979.0000
Reconciled Depreciation
808.0000
808.0000
1,187.0000
535.0000
525.0000
Net Income from Continuing Operation Net Minority Interest
-46,664.0000
-46,664.0000
-44,296.0000
-33,276.0000
-28,794.0000
Total Unusual Items Excluding Goodwill
--
--
-1,228.0000
--
--
Total Unusual Items
--
--
-1,228.0000
--
--
Normalized EBITDA
-40,633.0000
-40,633.0000
-37,830.0000
-29,144.0000
-24,705.0000
12/31/2020 - 11/8/2019
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

RPID Rapid Micro Biosystems, Inc.
0.8900
+3.49%
 
ARX.AX Aroa Biosurgery Limited
0.5000
-1.96%
 
LNSR LENSAR, Inc.
3.2300
+2.87%
 
TLSI TriSalus Life Sciences, Inc.
9.49
-3.46%
 
OSA ProSomnus, Inc.
0.4700
0.00%
 
DCTH Delcath Systems, Inc.
4.8700
+3.73%
 
LUCD Lucid Diagnostics Inc.
0.7965
-0.31%
 
TMCI Treace Medical Concepts, Inc.
10.97
-2.66%
 
TBIO Telesis Bio, Inc.
0.3090
-6.42%
 
RCEL AVITA Medical, Inc.
8.64
-2.59%